As we head into AACR 2026, we’ll be showcasing how optimized extraction can enable simpler, lower-cost, and more scalable assays for early-stage cancer detection and MRD. Visit us at Booth #3345 to learn more about Revolution Pro learn more https://t.co/OtFUKsSMgR #aacr2026
MCED and MRD assays continue to evolve, yet early detection often hinges on a single factor: nucleic acid extraction. Higher analyte yield drives greater sensitivity—and earlier insight into rare cancer markers. Let's talk.
#LiquidBiopsy#MRD#MCED#MolecularDiagnostics
NEW METHOD: Faster, higher yield protocol for direct extraction of #liquidbiopsy analytes from whole urine presented in our poster at the 10th Liquid Biopsy for Precision Oncology Summit earlier this week. See it here: https://t.co/N67nmTEMFo
Hello from #AMP2025 in Boston! 👋
Stop by Booth #1029 tomorrow when the Exhibit Hall opens at 11:15 AM ET to talk #liquidbiopsy with nRichDX.
Don’t miss Dr. Rena Xian (JHU) at 12 Noon, Stage 1 in the Exhibit Hall.
#Oncology#AMPath2025
For those attending the Association for Molecular Pathology (AMP) 2025 Annual Meeting & Expo this week, we look forward to seeing you! Join the conversation on liquid biopsy in Boston at the nRichDX Booth 1029.
#AMPath2025#LiquidBiopsy#cfDNA#cfRNA#Oncology#CancerDiagnostics
📍 Let’s meet at AMP 2025 in Boston!
nRichDX will be at the Association for Molecular Pathology (AMP) 2025 Annual Meeting & Expo, November 11–15.
More info and schedule a convenient appt: https://t.co/svVUfHmMyz
#AMPath2025#liquidbiopsy#PrecisionMedicine#oncologyresearch
Webinar next week - Daniel Kim of UCSC on cfRNA and liquid biopsy, Thursday, October 16. Note updated title - same content & presenters.
Registrants receive links to the live webinar beforehand and to the recorded webinar. https://t.co/vlPXrKRIhd
#Webinar#liquidbiopsy#cfRNA
Our next webinar with RNA #liquidbiopsy researcher Daniel Kim, PhD of UC Santa Cruz is scheduled for Thursday, October 16th at 9am PST / 12 Noon EST / 6pm CET! More info. and webinar registration at, https://t.co/6ZksSHxRor #webinar#sampleprep#cfRNA#ctRNA#oncologyresearch
cf/ctRNA offers a more dynamic view of a tumor's molecular landscape as compared to cfDNA alone.
We make it easy w/ nRichDX's Revolution cfTNA Max 20 and Max 50 kits. More info and request a demonstration with your samples:
https://t.co/uttjRaVdIF
#cfDNA#cfRNA#cfTNA#SamplePrep
Think sample prep doesn't impact liquid biopsy results? Check out this new paper out of Dartmouth titled, "Standardized Workflow and Analytical Validation of Cell-Free DNA Extraction for Liquid Biopsy Using a Magnetic Bead-Based Cartridge System" https://t.co/R7zgfmtBHb
New publication out of Dartmouth using nRichDX's Revolution System for #liquidbiopsy.
"The workflow also showed robust performance under different study parameters, variable sample conditions..."
https://t.co/8d1DZWgbN8
Doing liquid biopsy sample extraction with columns? See the new article titled, "Full-Length Clonal Immunoglobulin Rearrangements in cfDNA: Improved Recovery and Sequencing" from JHU's Xian et al. in the June issue of Clinical Chemistry Tired of columns? Contact nRichDX.
A good first day at booth #4641 for nRichDX at #AACR25. Pleased to have #liquidbiopsy leaders Prof. Dr. Klaus Pantel and Dr. Catherine Alix-Panabières stop by the nRichDX booth for a chat! If interested in liquid biopsy and maximizing isolation of cfDNA, cfRNA, & CTC's stop by!
Headed to AACR25? Stop by nRichDX booth #4641 and say "Hi!" or set an app't on the date and time of your choosing at the link below. We'd love to discuss your liquid biopsy project or answer questions. https://t.co/puUVafcqVE